Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections in Critically Ill Patients

NCT06843668 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT06843668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06843668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections in Critically Ill Patients
Lead sponsor
Mansoura University
Phase
Phase 2/3
Overall status
Recruiting
Start date
December 25, 2023
Completion date
October 25, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical ill patients, multi drug resistant